Covid19-Sources

4433 bookmarks
Custom sorting
Risks of Severe Acute Respiratory Syndrome Coronavirus 2 JN.1 Infection and Coronavirus Disease 2019–Associated Emergency Department Visits/Hospitalizations Following Updated Boosters and Prior Infection: A Population-Based Cohort Study
Risks of Severe Acute Respiratory Syndrome Coronavirus 2 JN.1 Infection and Coronavirus Disease 2019–Associated Emergency Department Visits/Hospitalizations Following Updated Boosters and Prior Infection: A Population-Based Cohort Study
Receipt of updated XBB1.5 vaccines 8-120 days earlier was associated with lower risk of severe acute respiratory syndrome coronavirus 2 infection, emergenc
·academic.oup.com·
Risks of Severe Acute Respiratory Syndrome Coronavirus 2 JN.1 Infection and Coronavirus Disease 2019–Associated Emergency Department Visits/Hospitalizations Following Updated Boosters and Prior Infection: A Population-Based Cohort Study
Differential decline of SARS‐CoV‐2‐specific antibody levels, innate and adaptive immune cells, and shift of Th1/inflammatory to Th2 serum cytokine levels long after first COVID‐19
Differential decline of SARS‐CoV‐2‐specific antibody levels, innate and adaptive immune cells, and shift of Th1/inflammatory to Th2 serum cytokine levels long after first COVID‐19
COVID-19 leads to a sustained reduction of immune cells of the myeloid and lymphoid cell lineages even 10 months after the first infection. Ten months after the first infection, S- and RBD-specific I...
·onlinelibrary.wiley.com·
Differential decline of SARS‐CoV‐2‐specific antibody levels, innate and adaptive immune cells, and shift of Th1/inflammatory to Th2 serum cytokine levels long after first COVID‐19
Differences in airborne stability of SARS-CoV-2 variants of concern is impacted by alkalinity of surrogates of respiratory aerosol | Journal of The Royal Society Interface
Differences in airborne stability of SARS-CoV-2 variants of concern is impacted by alkalinity of surrogates of respiratory aerosol | Journal of The Royal Society Interface
The mechanistic factors hypothesized to be key drivers for the loss of infectivity of viruses in the aerosol phase often remain speculative. Using a next-generation bioaerosol technology, we report measurements of the aero-stability of several SARS-CoV-2 ...
·royalsocietypublishing.org·
Differences in airborne stability of SARS-CoV-2 variants of concern is impacted by alkalinity of surrogates of respiratory aerosol | Journal of The Royal Society Interface
Favorable Antiviral Effect of Metformin on Severe Acute Respiratory Syndrome Coronavirus 2 Viral Load in a Randomized, Placebo-Controlled Clinical Trial of Coronavirus Disease 2019
Favorable Antiviral Effect of Metformin on Severe Acute Respiratory Syndrome Coronavirus 2 Viral Load in a Randomized, Placebo-Controlled Clinical Trial of Coronavirus Disease 2019
In a randomized trial of standard-risk adults, metformin decreased severe acute respiratory syndrome coronavirus 2 viral loads by an average of 0.56 log10
·academic.oup.com·
Favorable Antiviral Effect of Metformin on Severe Acute Respiratory Syndrome Coronavirus 2 Viral Load in a Randomized, Placebo-Controlled Clinical Trial of Coronavirus Disease 2019
SARS-CoV-2 spike-induced syncytia are senescent and contribute to exacerbated heart failure
SARS-CoV-2 spike-induced syncytia are senescent and contribute to exacerbated heart failure
Author summary In this paper, we directly linked SARS-2-S-triggered syncytium formation in the absence of infection with the ensuing induction of cellular senescence and its pathophysiological contribution to heart failure. We propose that both SARS-2-S expression and SARS-2-S protein internalization were sufficient to induce senescence in nonsenescent ACE2-expressing cells. This is important because of the persistent existence of SARS-2-S or extracellular vesicles containing SARS-2-S during the post-acute stages of SARS-CoV-2 infection in human subjects. In searching for the underlying molecular mechanisms determining syncytial fate, the formation of functional MAVS aggregates dependent on RIG-I was observed at an early stage during fusion and regulated the anti-death to senescence fate of SARS-2-S syncytia through the TNFα-TNFR2 axis. We also found impaired cardiac metabolism in SARS-2-S syncytia induced by condensed WNK1. However, syncytium formation or cellular senescence observed with the wild-type fusogenic S protein does not occur with the spike proteins produced by currently approved COVID-19 mRNA vaccines. Importantly, SARS-2-S-exacerbated heart failure could be largely rescued by WNK1 inhibitor, anti-syncytial drug or senolytic agent. Together, we suggest that rescuing metabolism dysfunction in senescent SARS-2-S syncytia should be taken into consideration in individuals with post-acute sequelae of COVID-19 (PASC).
·journals.plos.org·
SARS-CoV-2 spike-induced syncytia are senescent and contribute to exacerbated heart failure
„Mit“ oder „an“ Covid-19 gestorben? Studie liefert neue Zahlen - WELT
„Mit“ oder „an“ Covid-19 gestorben? Studie liefert neue Zahlen - WELT
Immer wieder gibt es Diskussionen darüber, ob die Menschen „mit“ oder „am“ Coronavirus gestorben sind. Eine Antwort liefert das Covid-19-Autopsie-Register, in dem die deutschlandweiten Obduktionsergebnisse von Corona-Toten erfasst werden. Forscher haben diese nun erstmals ausgewertet.
·welt.de·
„Mit“ oder „an“ Covid-19 gestorben? Studie liefert neue Zahlen - WELT
Impact of waning immunity against SARS-CoV-2 severity exacerbated by vaccine hesitancy
Impact of waning immunity against SARS-CoV-2 severity exacerbated by vaccine hesitancy
Author summary While the SARS-CoV-2 outbreak continues, the deployment of vaccines in many regions has blunted the severity of SARS-CoV-2 infections and decreased hospitalizations. However, the medium-term impacts of the duration of severity-blocking immunity, and its potential interactions with heterogeneous vaccine uptake (e.g. from vaccine hesitancy) or more robust vaccines, remain unknown. To titrate these effects, we use immuno-epidemiological models to examine potential future scenarios. We find that sufficient vaccine hesitancy (and correspondingly higher vaccination rates among adopters) can rapidly increase the fraction of individuals infected after waned severity-blocking immunity even when robust vaccines are deployed. This result underlines that pharmaceutical developments for broadly protective vaccines should be combined with campaigns to increase vaccine uptake globally. We also show that this fraction is highly dependent on underlying immune uncertainties, which illustrates the importance of accurately measuring immune parameters for proper prediction based on hospitalization data.
·journals.plos.org·
Impact of waning immunity against SARS-CoV-2 severity exacerbated by vaccine hesitancy